SoftBank Seeks Multibillion-Dollar Stake in Uber

SoftBank is pushing to take a commanding stake in the ride-hailing market, angling for a piece of Uber after spreading its bets across a trio of Asian startups.

 
Michael Kors to Buy Jimmy Choo for $1.2 Billion

Luxury-fashion company Michael Kors has reached a deal to buy Jimmy Choo for $1.17 billion, giving it a new avenue for growth as its core handbag market slows.

 
Barnes & Noble Is Urged to Sell Itself

Barnes & Nobel is being pushed to sell itself by Sandell Asset Management, which says the beleaguered bookseller could benefit from fresh investment.

 
Sony Restructures Television Unit

Sony Pictures Entertainment has restructured its television production unit in the wake of two top executives departing last month to oversee's push into creating original content.

 
Who Owns HNA? We Still Don't Know

China's acquisitive HNA Group has disclosed more than ever about its owners. That won't stop the questions.

 
U.K. Opens Corruption Probe in Rio Tinto in Guinea

The U.K.'s Serious Fraud Office said Monday it opened an investigation into suspected corrupt activities by mining giant Rio Tinto in Guinea.

 
Daimler Gets a Foothold in China's Self-Driving Car Market

Mercedes-Benz parent Daimler is investing in a Chinese self-driving startup, in another instance of a Western auto maker seeking out a Chinese partner to get a foothold in a challenging market.

 
Freight-Booking Startup Raises $62 Million

Digital freight-booking startup Convoy raised $62 million in a funding round led by Silicon Valley startup accelerator Y Combinator, money the company said it plans to use to expand nationally.

 
J.C. Penney Picks Former Darden, Wal-Mart Executive for CFO Role

J.C. Penney Co. named Jeffrey Davis its new finance chief Monday, an external hire with experience in the retail and restaurant industries.

 
AbbVie Ordered to Pay $150 Million in AndroGel Lawsuit

A federal-court jury in Chicago ordered drugmaker AbbVie to pay $150 million in punitive damages to an Oregon man after finding the company liable for fraudulent misrepresentations about the safety of the testosterone-replacement therapy AndroGel, according to court records.

(END) Dow Jones Newswires

July 25, 2017 05:00 ET (09:00 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.